Chakma Justin
ARS Pharmaceuticals, Inc. · Chief Business Officer
Chakma Justin is listed in filings as Chief Business Officer at ARS Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including sale activity. Recent filings connect the profile to ARS Pharmaceuticals, Inc. (SPRY). The current snapshot covers public activity from Nov 27, 2024 to Jan 5, 2026. Reported amounts are shown as $359.8K to $459.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $360k25k shares | SellNov 27, 2024 | $14.39 | $7.46 | |
| $593k42.2k shares | SellNov 26, 2024 | $14.05 | $7.46 | |
| $459k32.8k shares | SellNov 25, 2024 | $14.00 | $7.46 | |
| $615k45k shares | SellDec 2, 2024 | $13.67 | $7.46 | |
| $593k45k shares | SellDec 3, 2024 | $13.19 | $7.46 | |
| $712k50k shares | SellDec 6, 2024 | $14.23 | $7.46 | |
| $628k45k shares | SellDec 4, 2024 | $13.95 | $7.46 | |
| $702k49.6k shares | SellDec 5, 2024 | $14.13 | $7.46 | |
| $658k50k shares | SellDec 10, 2024 | $13.15 | $7.46 | |
| $1M117.3k shares | SellDec 12, 2024 | $12.27 | $7.46 | |
| $329k27.3k shares | SellDec 13, 2024 | $12.06 | $7.46 |